← All trials
NCT04313335
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2020
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2022
- First posted
- Mar 18, 2020
- Last posted
- Mar 26, 2020
- Enrollment
- 750
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Capital Medical UniversityLead sponsor
- Capital Medical UniversityReponsible party - principal investigator
- Tianjin Medical UniversityCollaborator
- Tsinghua UniversityCollaborator
- China Medical UniversityCollaborator
- Peking UniversityCollaborator
- Shandong Provincial HospitalCollaborator
- Cangzhou Central HospitalCollaborator
- Huai'an Second People's HospitalCollaborator
- Fujian Provincial HospitalCollaborator
- Baoding First Center HospitalCollaborator
- Linfen Fourth People's HospitalCollaborator
- Shanxi Medical UniversityCollaborator
- Zhengzhou UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.